#Bionyra, a #Paris and #Boston-based clinical-stage biopharma company developing next-generation biologics for immune-mediated inflammatory diseases, announced their launch and a €143 million #SeriesA 🇫🇷 💊

https://t.co/fTcNTAIbnH
1
Ai ajuns la finalul listei 🎉